Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Hormone Therapy for Newly Diagnosed Metastatic Prostate Cancer
NCT00363285Phase 3Unknown
- Sponsor
- St Bartholomew's Hospital
- Start
- Jan 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cyproterone in prostate cancer (PCa), sponsored by St Bartholomew's Hospital. Status: unknown.
02
Drugs
cyproterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00363285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363285.